Shire (SHPG) Numbers Taken Higher at Jefferies

Jefferies analyst David Steinberg raised estimates and his price target on Buy-rated Shire (NASDAQ: SHPG) to $205.00 (from $108.00).

He said, "Post strong bottom line results, we are raising our EPS estimates 3-4% through 2018 reflecting both greater operating leverage based on management’s updated expense outlook and the inclusion of a new ADHD candidate (SPD465) that could emerge in 2H15. We continue to see Shire as a core holding in Specialty Pharma and raise our PT to $205."

The firm raised current quarter estimates from $2.37 to $2.43, FY 2014 EPS from $9.45 to $9.72 and FY 2015 EPS from $10.65 to $10.83.

For an analyst ratings summary and ratings history on Shire click here. For more ratings news on Shire click here.

Shares of Shire closed at $175.87 yesterday.

You May Also Be Interested In

• Evercore ISI Downgrades Reddit (RDDT) to In Line, Removes From Tactical Outperform List
• Alnylam Pharmaceuticals (ALNY) PT Lowered to $350 at Freedom Broker
• Reddit (RDDT) PT Lowered to $145 at Piper Sandler